Gamida Cell Ltd. Ordinary Shares
GMDA
GMDA was delisted on the 5th of April, 2024.
73 hedge funds and large institutions have $84.6M invested in Gamida Cell Ltd. Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 12 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
25% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 12
4% more funds holding
Funds holding: 70 → 73 (+3)
46% less capital invested
Capital invested by funds: $157M → $84.6M (-$72.4M)
55% less call options, than puts
Call options by funds: $74K | Put options by funds: $164K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$6.4M |
| 2 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$2.49M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.86M |
| 4 |
Renaissance Technologies
New York
|
+$1.61M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$18.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.1M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.14M |
| 4 |
JP Morgan Chase
New York
|
-$2.66M |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$687K |
GMDA Hedge Fund Activity: Q3 2021 in Review
73 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q3 2021, worth a combined $84.6M — down 46% from $157M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new GMDA positions and 12 closed out — a net gain of 3 holders — while 23 added to existing stakes and 17 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $6.4M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $18.3M sold.
- 73 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q3 2021, up from 70 in Q2 2021.
- Funds reported $84.6M of Gamida Cell Ltd. Ordinary Shares stock for Q3 2021, down 46% quarter-over-quarter.
- 15 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q3 2021 and 12 closed out, a net change of +3 holders.
- The largest Gamida Cell Ltd. Ordinary Shares buyer in Q3 2021 was Stonepine Capital Management, an estimated $6.4M added.
- The largest Gamida Cell Ltd. Ordinary Shares seller in Q3 2021 was Consonance Capital Management, an estimated $18.3M sold.
Based on aggregated 13F filings for Q3 2021.